The Orexin-A/OX1R System Induces Cell Death in Pancreatic Cancer Cells Resistant to Gemcitabine and Nab-Paclitaxel Treatment

Pancreatic ductal adenocarcinoma (PDAC) represents the fourth cause of cancer-associated death in the West. This type of cancer has a very poor prognosis notably due to the development of chemoresistance when treatments including gemcitabine and Abraxane (Nab-paclitaxel) were prescribed. The identif...

Descripción completa

Detalles Bibliográficos
Autores principales: Voisin, Thierry, Nicole, Pascal, Gratio, Valérie, Chassac, Anaïs, Mansour, Dounia, Rebours, Vinciane, Couvelard, Anne, Couvineau, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209740/
https://www.ncbi.nlm.nih.gov/pubmed/35747788
http://dx.doi.org/10.3389/fonc.2022.904327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209740/
https://www.ncbi.nlm.nih.gov/pubmed/35747788
http://dx.doi.org/10.3389/fonc.2022.904327

Ejemplares similares